Journal of Nephrology & Therapeutics

3^rd International Conference on Nephrology & Therapeutics

June 26-27, 2014 Valencia Conference Centre, Valencia, Spain

Accepted Abstracts

• Adherence medical prescription: What’s new?

  A Guerraoui

  PDF HTML

• Medication adherence to phosphate binders: The cheobs study

  A Guerraoui, P Chauveau, F Zenasni, L Idier and C Isnard Bagnis

  PDF HTML

• Comparative effects of the anti-hypertensive drugs, ramipril and irbesartan, on the vascular protection in the kidney of diabetic rats

  Abdulmonim A Alqasim, Ghazi A Bamagus and Sami H Hammadi

  PDF HTML

• Hemodynamic response to exercise predicts the development of severe renal failure: Revealing a cardio-renal secret cross talk

  Ali Reza Khoshdel, Shane Carney, Saxon White and Alastair Gillies

  PDF HTML

• Prevention of drug nephrotoxicity with antioxidant co-therapies

  Ana Isabel Morales Martín

  PDF HTML

• Model for deceased donor transplantation- Tamil Nadu experience

  Ashish Verma

  PDF HTML

• Vascular calcification in patients’ with peritoneal dialysis

  Augusto Octavio Salinas Meneses

  PDF HTML

• WRN- Warfarin related nephropathy in human and experimental animals

  Sergey V Brodsky

  PDF HTML

• Water renal handling alteration in HIV stable patients

  Carlos G. Musso

  PDF HTML

• Investigation of Hellenic families with microscopic hematuria reveals the frequency of collagen IV mutations and evidence for activation of the unfolded protein response

  Constantinos Deltas

  PDF HTML

• Functional iron deficiency: A diagnostic challenge for the laboratory

  Eloísa Urrechaga

  PDF HTML

• Oxidative stress issues and antioxidant treatment in CKD patients

  Evgueniy Stefanov Vazelov

  PDF HTML

• In Argentina vascular calcification: The use of radiology as a method of choice for diagnosis and subsequent treatment in patients with CKD stage 5 and 5D

  Fabian Otreras

  PDF HTML

• New theranostic strategies for drug-induced acute kidney injury

  Francisco J Lopez-Hernandez

  PDF HTML

• Circadian variation of mineral and bone parameters in end-stage renal disease

  Hariprasad Trivedi

  PDF HTML

• Proteomic analysis of the effects of farnesyltransferase inhibitor on vascular disease in experimental model of chronic renal failure

  Igor G Nikolov

  PDF HTML

• The use of cognitive analytic therapy with patients who mismanage their diabetes

  Jacqueline Fosbury

  PDF HTML

• Creating an oligopoly in the treatment of end stage renal disease and the subsequent impact on home hemodialysis therapies in the United States

  John D Sullivan

  PDF HTML

• Epicardial adipose tissue and its relation with arterial calcification in CKD patients

  Luis D’Marco

  PDF HTML

• Biological therapies and lupus nephritis

  Luis Enrique Herrera Jiménez

  PDF HTML

• Renal transplantation in Algeria

  Lydia Benhocine

  PDF HTML

• Single nucleotide polymorphisms (SNPs) in the outcome of tacrolimus treatment in renal transplantation

  María José Herrero

  PDF HTML

• Pediatric peritoneal dialysis: Experience in Guatemala

  Claudia Maribel Patal

  PDF HTML

• Novel therapies for treating hyponatremia

  Michael F Michelis

  PDF HTML

• Losartan treatment diminishes kidney injuries and improves glomerular filtration in hypertensive rats with ischemic acute kidney injury

  Milan Ivanov, Nevena Mihailovic-Stanojevic, Jelica Grujic Milanovic, Durđica Jovovic, Danijela Karanovic, Una-Jovana Vajic, Zoran Miloradovic and Jasmina Markovic Lipkovski

  PDF HTML

• HIV-1 infection and the kidney

  Mohamed G Atta

  PDF HTML

• Reno-protective effects of herbal medicines: Introducing a systematic approach towards reliable therapeutic effect (I’START)

  Osama M Arafat

  PDF HTML

• Renal dopamine receptors, oxidative stress, and hypertension

  Pedro A Jose, Santiago Cuevas, Yu Yang, Van Anthony Villar, Peiying Yu, Laureano D Asico and Ines Armando

  PDF HTML

• Screening for microalbuminuria in adolescents with type 1 diabetes

  Pinhas Geva

  PDF HTML

• Uric acid and its role in kidney disease

  Raj P Singh

  PDF HTML

• Urinary 8-iso-prostaglandin F2α and serum malondialdehyde relationship with estimated Glomerular Filtration Rate (eGFR) and urine albumin to creatinine ratio

  Rani Sauriasari

  PDF HTML

• Hepatorenal syndrome

  Salwa lbrahim

  PDF HTML

• Biological basis for rational use of erythropoietin stimulating agents

  Mark S Segal

  PDF HTML

• Catheter-related blood stream infections; where are we standing?

  Sofia Sofroniadou

  PDF HTML

• A successful model of organ donation and transplantation

  Stela Živčić-Ćosić

  PDF HTML

• Medication adherence and factors influencing medication adherence among haemodialysis patients

  Tan Sing Shia

  PDF HTML

• Renal dysfunction in neonates due to in utero exposure to medications

  Varsha Phadke

  PDF HTML

• Postconditioning is life saving in an animal model of acute renal failure

  Xiuying Zhang

  PDF HTML

• Insulin resistance in chronic kidney disease: Is it a hepatic Cushings?

  Muhammad Magdi Yaqoob

  PDF HTML

• Use of CGMS in reducing glycaemic variability and morbidity in patients with CKD

  Rajiv Kovil

  PDF HTML

• An appraisal of nephroprotection and the scope of natural products in combating renal disorders

  Qazi Zaid Ahmad, Nasreen Jahan, Ghufran Ahmad and Tajuddin

  PDF HTML

• Study of Portulaca oleracea for its nephroprotective effect against Gentamycin and Doxorubicin induced nephrotoxicity

  Ghufran Ahmad and Salma Jabeen

  PDF HTML